Search research articles
Contact Us
Filters
Showing results (51-60 of 140) with videos related to
Page
of 14
Sort By:
British Journal of Clinical Pharmacology
|
February 25, 2024
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach
Alexandre Acramel, Sandy Blondeel-Gomes, Mathilde Dupré, et al.
ESMO Open
|
September 27, 2019
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
Ines Vaz-Luis, Paul Cottu, Christel Mesleard, et al.
Breast (Edinburgh, Scotland)
|
April 8, 2026
Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice
Hope S Rugo, Adam Brufsky, Rachel M Layman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2010
Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma
Nadège Gruel, Carlo Lucchesi, Virginie Raynal, et al.
Oncotarget
|
September 8, 2016
ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas
Gabrielle Deniziaut, Jean Christophe Tille, François-Clément Bidard, et al.
Bulletin Du Cancer
|
April 30, 2011
[Concurrent whole-brain radiotherapy with trastuzumab for treatment of brain metastases in breast cancer patients: questions and answers]
Hind Riahi Idrissi, Cyrus Chargari, Marc A Bollet, et al.
JMIR Research Protocols
|
January 12, 2022
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study
Anne Brédart, Aude Rault, Johanna Terrasson, et al.
International Journal of Cancer
|
November 28, 2008
Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype
Patricia de Cremoux, Anne de la Rochefordière, Alexia Savignoni, et al.
BMJ Supportive & Palliative Care
|
April 30, 2021
Advanced cancer and COVID-19 comorbidity: medical oncology-palliative medicine ethics meetings in a comprehensive cancer centre
Laura Thery, Pauline Vaflard, Perrine Vuagnat, et al.
British Journal of Cancer
|
January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
Luc Cabel, Frédérique Berger, Paul Cottu, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 140) with videos related to
Sort By:
Page
of 14
British Journal of Clinical Pharmacology
|
February 25, 2024
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach
Alexandre Acramel, Sandy Blondeel-Gomes, Mathilde Dupré, et al.
ESMO Open
|
September 27, 2019
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
Ines Vaz-Luis, Paul Cottu, Christel Mesleard, et al.
Breast (Edinburgh, Scotland)
|
April 8, 2026
Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice
Hope S Rugo, Adam Brufsky, Rachel M Layman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2010
Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma
Nadège Gruel, Carlo Lucchesi, Virginie Raynal, et al.
Oncotarget
|
September 8, 2016
ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas
Gabrielle Deniziaut, Jean Christophe Tille, François-Clément Bidard, et al.
Bulletin Du Cancer
|
April 30, 2011
[Concurrent whole-brain radiotherapy with trastuzumab for treatment of brain metastases in breast cancer patients: questions and answers]
Hind Riahi Idrissi, Cyrus Chargari, Marc A Bollet, et al.
JMIR Research Protocols
|
January 12, 2022
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study
Anne Brédart, Aude Rault, Johanna Terrasson, et al.
International Journal of Cancer
|
November 28, 2008
Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype
Patricia de Cremoux, Anne de la Rochefordière, Alexia Savignoni, et al.
BMJ Supportive & Palliative Care
|
April 30, 2021
Advanced cancer and COVID-19 comorbidity: medical oncology-palliative medicine ethics meetings in a comprehensive cancer centre
Laura Thery, Pauline Vaflard, Perrine Vuagnat, et al.
British Journal of Cancer
|
January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
Luc Cabel, Frédérique Berger, Paul Cottu, et al.
Page
of 14